Insulin has been shown to directly affect blood vessel tone and to pro
mote vascular hypertrophy, but the mechanism of these actions remains
uncertain. Because angiotensin I (Ang I)-converting enzyme inhibitors
have been shown to improve insulin action and to impede the progressio
n of vascular hypertrophy in hypertensive animal models, it is possibl
e that the vascular properties of insulin may be mediated through the
tissue renin-angiotensin system (RAS), To evaluate this relationship,
we first investigated the effect of insulin on components of the RAS u
sing cultured rat vascular smooth muscle cells (VSMCs). Insulin treatm
ent (1000 mu U/mL) markedly increased angiotensinogen mRNA expression
and angiotensinogen production. We next investigated the role of the R
AS in insulin-mediated cell proliferation, using [H-3]thymidine uptake
. Studies were done both with insulin alone and in the presence of cap
topril (1 X 10(-5) to 10(-5) mol/L) and losartan (1 x 10(-9) to 10(-7)
mol/L). [H-3]Thymidine uptake was increased significantly by 1000 mu
U/mL insulin, and this stimulation was reduced by 1 x 10(-6) mol/L cap
topril (-38.8%. P<0.05) and by 1 X 10(-8) mol/L losartan (-37.5%, P<0.
05). Further studies showed that the degree of insulin-mediated [H-3]t
hymidine uptake in VSMCs could be duplicated by 4 X 10(-10) mol/L Ang
II. Losartan reduced the effects of both Ang II and insulin on [H-3]th
ymidine uptake by about 40% to 45% of baseline (P<0.05). Captopril red
uced insulin-mediated [H-3]-thymidine uptake but did not affect Ang II
-mediated [H-3]thymidine uptake. In summary, insulin induced significa
nt stimulation of angiotensinogen expression and production and stimul
ated growth similar to that seen with Ang II in cultured rat VSMCs, In
hibition of Ang II production or its binding to the Ang IT type 1 (AT(
1)) receptor inhibited insulin-mediated growth in a fashion similar to
that seen with inhibition of Ang II-mediated growth. Thus, insulin ca
n modulate the vascular RAS, and the effect of insulin on vascular gro
wth may be via direct effects on angiotensinogen expression and transl
ation operative through both the AT(1) receptor and the conversion of
Ang I to Ang II.